Journal article
Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation
CS Samuel, I Mookerjee, ML Halls, RJ Summers, E Chew, RAD Bathgate, GW Tregear, TD Hewitson
Annals of the New York Academy of Sciences | BLACKWELL PUBLISHING | Published : 2009
Abstract
Derived from fibroblasts, myofibroblasts are the principal cells that are responsible for the synthesis and reorganization of excess matrix in renal interstitial fibrosis. Recognized from their de novo expression of α-smooth muscle actin, myofibroblast differentiation and activity can be influenced by several factors, including a combination of growth factors and other soluble mediators, extracellular matrix components, and mechanical stress. Relaxin has previously been shown to inhibit renal myofibroblast differentiation in vitro, an effect partly mediated through its ability to interfere with the transforming growth factor-β1 (TGF-β1r∥ pathway via inhibition of Smad2 phosphorylation and tr..
View full abstractGrants
Awarded by Australian Research Council linkage
Funding Acknowledgements
This study was Supported by a National Heart Foundation of Australia/National Health & Medical Research Council (NHMRC) RD VVright Fellowship to C. S. Samuel, a Howard Florey Institute Postgraduate Scholarship to I. Mookerjee, an Australian Postgraduate Scholarship to M. L. Halls, NHMRC Senior Research Fellowships to R. A. D. Bathgate and G. 1,V Tregear, and an Australian Research Council linkage grant (LP05606020).